Table 2 Distribution of differences among EQ-5D-5 L domain responses at baseline survey.

From: Effect of pharmacist led intervention on health related quality of life in diabetic patients assessed using EQ5D domains and visual analogue scale

Dimension

Control group

N (%)

Intervention group

N (%)

p-value

Effect size

Mobility

 No problem at all

8 (5.7)

12 (7.8)

0.272*

-

 Minor problems

15 (10.6)

14 (9.2)

 Medium problems

66 (46.8)

77 (50.3)

 Serious problems

44 (31.2)

34 (22.2)

 Incapable for walk

about

8 (5.7)

16 (10.5)

Self-care

 No problems

2 (1.4)

3 (2.0)

0.877**

-

 Minor problems

11 (7.8)

8 (5.2)

 Medium problems

51 (36.2)

61 (39.9)

 Serious problems

39 (27.7)

40 (26.1)

 Incapable to wash

or dress

38 (27.0)

41 (26.8)

Usual activities

 No problem at all

31 (22.0)

39 (25.5)

0.625*

-

 Minor problems

30 (21.3)

32 (20.9)

 Medium problems

23 (16.3)

18 (11.8)

 Serious problems

51 (36.2)

53 (36.6)

 Incapable to do

usual activities

6 (4.3)

11 (7.2)

Pain/discomfort

 No pain/discomfort

24 (17.0)

26 (17.0)

0.970*

-

 Minor pain/discomfort

23 (16.3)

24 (15.7)

 Medium pain/discomfort

50 (35.5)

60 (39.2)

 Serious pain/discomfort

30 (21.3)

29 (19.0)

 Extremely painful/discomfort

14 (9.9)

14 (9.2)

Anxiety/depression

 Not anxious/depressed

54 (38.3)

55 (35.9)

0.819**

-

 Minor anxious/depressed

41 (29.1)

53 (34.6)

 Medium anxious/depressed

32 (22.7)

31 (20.3)

 Serious anxious/depressed

11 (7.8)

10 (6.5)

 Extremely distressed /

depressed

3 (2.1)

4 (2.6)

  1. Significant values are in [italics].
  2. *Chi-square test. **Fisher exact test #Phi & Cramer’s v.